nano-eggshell varnish

Preclinical

MMansoura University

nano-eggshell varnish is one of 8 therapeutic programs targeting Dental Caries. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Dental CariesRecruiting

Dental CariesPreclinical

Recruiting

Competition

Competitive Landscape

7 competitors in Dental Caries

#DrugCompanyPhaseTrials

Zocor

OOrganon and Co

Approved

—2

Peridex

DDexcel Pharma Technologies Ltd.

Approved

—3

Betadine

BBecton, Dickinson and Company

Mycostatin

KH001

1 6

Chlorhexidine Digluconate

GSK

Preclinical

1 7

Vancomycin Hydrochloride

WWake Forest University Health Sciences

Preclinical

1 8

nano-eggshell varnish

MMansoura University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

PreclinicalRecruiting

Dental Caries

NCT07711132

Clinical

Trials by Indication[1]

Dental Caries1 trial

Remineralizing Effect of Nano-eggshell, Casein Phosphopeptide Amorphous Calcium Phosphate (CPP-ACP), and Sodium Fluoride on Initial Enamel Caries: Randomized Controlled Trial

Recruiting·MMansoura University·Preclinical·NCT07711132·90 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for nano-eggshell varnish. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for nano-eggshell varnish. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Mansoura University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: MMansoura University

nano-eggshell varnish

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Dental Caries1 trial

References

Drug Info

Quick Facts

Related News